GYRE
Gyre Therapeutics Inc.
7.40$
+3.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -107.18 | -64.75 | -23.72 | -5.82 | -2.55 | -3.63 | -2.87 | -2.73 | 0.14 | 0.39 | -0.04 | 0.01 | |
| 1.09 | 1.59 | 0.50 | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
| 10.79 | 1.10 | 0.82 | 0.25 | 0.23 | 0.27 | 0.19 | 0.11 | 0.18 | 0.11 | 0.01 | 0.07 | |
| -19.79 | -21.20 | 1.07 | 0.17 | -0.12 | 0.68 | -0.13 | 0.02 | -0.10 | 0.11 | -0.15 | -0.15 | |
| 0.01 | 0.92 | 0.60 | 0.01 | 0.03 | 0.01 | 0.01 | 0.03 | 0.07 | 0.13 | 0.03 | 0.01 | |
| 105.23 | 126.52 | -1.68 | -3.29 | -6.36 | 2.28 | 0.50 | 1.57 | -0.18 | -0.30 | -0.19 | 0.00 | |
| – | – | – | 1.15 | – | – | – | 0.00 | 0.59 | – | – | – | |
| – | -0.28 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -0.22 | -0.01 | – | – | – | |
| 15.56 | 31.54 | 1.22 | 10.34 | 9.93 | 0.03 | 3.15 | 1.62 | -0.59 | 0.04 | 0.02 | 0.24 | |
| 6.05 | 93.31 | -24.18 | 1.23 | 1.02 | -1.32 | 0.78 | 0.46 | -0.07 | 0.13 | -0.21 | 0.24 | |
| -107.20 | -65.67 | -24.32 | -5.83 | -2.58 | -3.64 | -2.88 | -2.76 | 0.08 | 0.26 | -0.07 | 0.00 |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.